CellType vs OpenEvidence
Which Healthcare AI tool is better in 2026?
CellType
The agentic drug company. We simulate human biology
OpenEvidence
AI medical assistant for clinicians
Side-by-side
OpenEvidence is the more established option (raised $735M); pricing is comparable on both sides.
| Metric | CellType | OpenEvidence |
|---|---|---|
| Taglinei | The agentic drug company. We simulate human biology | AI medical assistant for clinicians |
| Foundedi | 2026 | 2022🏆 |
| HQi | New York, US | San Francisco, US |
| Employeesi | 1-10 | 50-200🏆 |
| Neuron scorei | 47 | 63🏆 |
| Total fundingi | $500K | $735M🏆 |
| Latest roundi | Seed · Jan 2026 | Series D · Jan 2026 |
| Valuationi | — | $12B🏆 |
| Cheapest paid plani | Pricing not disclosed | — |
| Free plani | ✗ | ✗ |
| Free triali | ✗ | ✗ |
| Top tier pricei | Pricing not disclosed | Enterprise · Contact sales |
| Pricing summaryi | Pricing not listed | 1 published plans |
| Categoriesi |
Capability matrix
Developer-facing capabilities and access signals for CellType and OpenEvidence.
| Capability | CellType | OpenEvidence |
|---|---|---|
| MCP support | ✗ | ✗ |
| Public API | ✗ | ✓ |
| Webhooks | ✗ | ✗ |
| OAuth 2.0 | ✗ | ✗ |
| SDK languages | — | 2 (TypeScript, Python) |
| Free plan | ✗ | ✗ |
| Free trial | ✗ | ✗ |
| Verified | ✗ | ✓ |
| Active deal | ✗ | ✗ |
🟢 Strengths of CellType
- Newer company (2026)
🔵 Strengths of OpenEvidence
- Has raised more capital ($735M vs $500K)
- Higher Neuron score (63 vs 47)
- More mature (2022)
- Verified profile
Which should you choose?
Choose OpenEvidence if price matters most — it starts at Freemium, which is friendlier for teams watching burn. Both AI Healthcare tools ship core features, so the cost delta often decides it for small teams and solo operators.
Choose OpenEvidence if you want the most established option — it has raised $735M, suggesting more runway for enterprise features, support, and long-term roadmap. For mission-critical workflows or larger teams, that stability often outweighs a lower monthly price.
Frequently asked questions
CellType vs OpenEvidence — which is better?
It depends on your priority. CellType is the leaner option; OpenEvidence has broader feature depth. See the side-by-side table above.
Is CellType cheaper than OpenEvidence?
No — OpenEvidence's cheapest paid plan is Freemium, while CellType's is Pricing not listed.
Do CellType and OpenEvidence offer free plans?
CellType: Paid only. OpenEvidence: Paid only.
Explore more AI Healthcare tools
Contextual paths to related AI startups, deals and rankings.